DemRisk, dementia prediction model that uses primary care data, can identify at-risk patients, especially those aged between 60 and 79.

Alzheimer dementia occurs at higher rates among adults with Down syndrome with a mean onset at age 54.5 and a disease duration of 4.6 years.

Dementia is a debilitating neurodegenerative disease that gradually diminishes life quality, leading to memory loss, ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

and Parkinson’s disease (PD), today announced that its President and CEO, Maria Maccecchini, Ph.D., has been invited to speak at the National Institute on Aging (NIA) workshop, “Dementia with Lewy ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Researchers believe it is associated with a few things, one of which being how difficult you find it to get to sleep ...

Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.

A combination of two “active” therapies may help slow cognitive decline in older adults, especially those with a type of severe depression and a genetic risk of Alzheimer's, a study indicates.

Feeling sleepy and less enthusiastic during the day may indicate a higher risk of developing a syndrome that often leads to ...